[1]
Arshad, A.R. et al. 2025. Not all Patients with Severe/Critical COVID-19 Pneumonia Benefit from Tocilizumab. Pakistan Armed Forces Medical Journal. 75, 4 (Aug. 2025), 626–630. DOI:https://doi.org/10.51253/pafmj.v75i4.8053.